To verify the safety of omission of lymph node dissection in ultra-low-risk endometrial cancer (KGOG criteria), we examine the survival of women with ultra-low-risk endometrial cancer who do not undergo lymph node dissection
Study Type
OBSERVATIONAL
Enrollment
153
do not undergo lymph node dissection
3 year recurrence free survival
3 year recurrence free survival
Time frame: 3 year since surgery
5 year recurrence free survival
5 year recurrence free survival
Time frame: 5 year since surgery
5 year overall survival
5 year overall survival
Time frame: 5 year since surgery
surgery time
from surgery start to end
Time frame: surgery visit
change of Functional Assessment of Cancer Therapy - General (FACT G) score from baseline
functional assessment of cancer therapy - general
Time frame: baseline - 1week - 5week - 3month - 6month
change of Gynecologic Cancer Lymphedema Questionnaire - Korean (GCLQ-K) score from baseline
gynecologic cancer lymphedema questionnaire - Korean
Time frame: baseline - 5week - 6month - 12month - 18month - 24month - 36month - 48month - 60month
change of Female Sexual Function Index (FSFI) score from baseline
female sexual function index
Time frame: baseline - 6month - 12month - 24month - 36month - 48month - 60month
length of stay
from admission to discharge
Time frame: surgery visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
transfusion
amount of transfusion
Time frame: surgery visit
hemoglobin decline
change of hemoglobin level from baseline to postoperative lowest level
Time frame: surgery visit
surgery complication
any surgery complications observed
Time frame: surgery visit